Quent Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Quent Capital's RGEN Position: Q2 2026 in Review
Quent Capital increased its Repligen (RGEN) stake by 17% in Q2 2026, buying an estimated $369 and bringing the position to 21 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.
Quent Capital first reported a position in RGEN in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.5K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Quent Capital held 21 shares of Repligen worth $2.87K as of Q2 2026.
- Quent Capital bought 3 Repligen shares in Q2 2026, an estimated $369.
- Repligen made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1431 holding.
- Quent Capital first reported a position in Repligen in Q4 2023 and has held it in 10 quarters since.
- Quent Capital's Repligen position peaked at $11.5K in Q4 2025.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.